Aphoenity International Holdings Inc. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q1 2025.
-
Location
-
Wanchai
-
Fiscal year end
-
31 December
-
Latest financial report
-
12 May 2025
Quick Takeaways
- Aphoenity International Holdings Inc. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q1 2025.
- Headline metric: Return On Equity -204%.
What Changed
- Return On Equity YoY change: <span class="text-red-600">-955%</span>.
- Most recent SEC facts end date: 30 Apr 2025.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original Filing
Latest SEC snapshot (2025-04-30) highlights Return On Equity -203.9%, Return On Assets -178.9%, and Current Ratio 0.12x.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
19.3/100
Weak
Confidence medium
Return On Equity
-204%
Metric score 0.0/100
Return On Assets
-179%
Metric score 0.0/100
Financial Health
- Current Ratio
- 0.12x
- Quick Ratio
- 0.12x
- Debt to Equity
- 0.06x
Watchpoints
Return On Equity, Return On Assets, and Current Ratio
Key metrics snapshot
Return On Equity
-204%
YoY: -955%
Industry median:
20%
(n=101)
View history
Return On Assets
-179%
YoY: -1806%
Industry median:
-9.9%
(n=98)
View history
Current Ratio
0.12x
YoY: -98%
Industry median:
1.13x
(n=97)
View history
Quick Ratio
0.12x
YoY: -98%
Industry median:
0.94x
(n=62)
View history
Debt-to-equity
0.06x
YoY: -63%
Industry median:
0.32x
(n=92)
View history
NetIncomeLoss YoY
-954%
YoY:
Industry median:
15%
(n=93)
View history
Profitability
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Return On Equity
|
-204%
|
-955%
|
20%
(n=101)
|
Q1 2025
|
Q1 2025
|
%
|
|
Return On Assets
|
-179%
|
-1806%
|
-9.9%
(n=98)
|
Q1 2025
|
Q1 2025
|
%
|
Financial Health
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Current Ratio
|
0.12x
|
-98%
|
1.13x
(n=97)
|
Q1 2025
|
Q1 2025
|
x
|
|
Quick Ratio
|
0.12x
|
-98%
|
0.94x
(n=62)
|
Q1 2025
|
Q1 2025
|
x
|
|
Debt-to-equity
|
0.06x
|
-63%
|
0.32x
(n=92)
|
Q1 2025
|
Q1 2025
|
x
|
Growth
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Revenues
|
$0
|
|
5.2%
(n=26)
|
Q1 2025
|
Q1 2025
|
USD
|
|
NetIncomeLoss YoY
|
-954%
|
|
15%
(n=93)
|
Q1 2025
|
Q1 2025
|
%
|
Share Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Entity Common Stock, Shares Outstanding
|
563,466,410
|
0%
|
Q1 2025
|
Q1 2025
|
shares
|
|
Common Stock, Shares, Outstanding
|
563,466,410
|
+11%
|
Q1 2025
|
Q1 2025
|
shares
|
|
Common Stock, Value, Issued
|
$56,347
|
+11%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Weighted Average Number of Shares Outstanding, Basic
|
563,466,410
|
+11%
|
Q1 2025
|
Q1 2025
|
shares
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
563,466,410
|
+11%
|
Q1 2025
|
Q1 2025
|
shares
|
Additional Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Cost of Revenue
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
General and Administrative Expense
|
$3,524
|
-29%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Operating Income (Loss)
|
$3,524
|
-100%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Nonoperating Income (Expense)
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
|
$3,524
|
-100%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Income Tax Expense (Benefit)
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Earnings Per Share, Basic
|
0
|
|
Q1 2025
|
Q1 2025
|
USD/shares
|
|
Earnings Per Share, Diluted
|
0
|
|
Q1 2025
|
Q1 2025
|
USD/shares
|
|
Inventory, Net
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Assets, Current
|
$12,055
|
-99%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Assets
|
$12,055
|
-100%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Liabilities, Current
|
$104,382
|
-61%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Liabilities
|
$104,382
|
-92%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Retained Earnings (Accumulated Deficit)
|
$22,786,438
|
-77%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Stockholders' Equity Attributable to Parent
|
$92,327
|
-101%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Liabilities and Equity
|
$12,055
|
-100%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Share-based Payment Arrangement, Noncash Expense
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Net Cash Provided by (Used in) Operating Activities
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Net Cash Provided by (Used in) Financing Activities
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Net Cash Provided by (Used in) Investing Activities
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Common Stock, Shares Authorized
|
1,000,000,000
|
0%
|
Q1 2025
|
Q1 2025
|
shares
|
|
Common Stock, Shares, Issued
|
563,466,410
|
+11%
|
Q1 2025
|
Q1 2025
|
shares
|
|
Common Stock, Par or Stated Value Per Share
|
0.0001
|
0%
|
Q1 2025
|
Q1 2025
|
USD/shares
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
|
$12,055
|
-92%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Interest Paid, Excluding Capitalized Interest, Operating Activities
|
$0
|
-100%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Depreciation
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Payments to Acquire Property, Plant, and Equipment
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Current Income Tax Expense (Benefit)
|
$0
|
|
Q1 2025
|
Q1 2025
|
USD
|
|
Preferred Stock, Shares Authorized
|
20,000,000
|
|
Q1 2025
|
Q1 2025
|
shares
|
|
Additional Paid in Capital
|
$22,637,764
|
0%
|
Q1 2025
|
Q1 2025
|
USD
|
|
Preferred Stock, Par or Stated Value Per Share
|
0.0001
|
|
Q1 2025
|
Q1 2025
|
USD/shares
|
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric |
Weight |
V1 threshold |
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY
Explore related SEC datasets